Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
Received 24 December 2019
Accepted for publication 8 April 2020
Published 24 April 2020 Volume 2020:13 Pages 107—113
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Everson L.A. Artifon
Robertha Baccaro Biondi, Pericles Sidnei Salmazo, Silméia Garcia Zanati Bazan, João Carlos Hueb, Sergio Alberto Rupp de Paiva, Ligia Yukie Sassaki
Department of Internal Medicine, Botucatu Medical School at Sao Paulo State University (UNESP), Botucatu, Brazil
Correspondence: Ligia Yukie Sassaki
Department of Internal Medicine, São Paulo State University (UNESP), Medical School, Botucatu CEP 18618-970, Brazil
Tel +5514 38801171
Fax +55 14 38801667
Background: Inflammatory bowel disease (IBD) patients present a higher risk of developing cardiovascular diseases due to the presence of chronic inflammation, which plays an essential role in atherogenesis. Therefore, the aim of the study was to evaluate the cardiovascular risk between patients with IBD and healthy control individuals.
Materials and Methods: A total of 52 consecutive IBD outpatients from a tertiary hospital and 37 healthy controls were enrolled. Data collected included age, sex, smoking status, presence of comorbidities, disease activity, ongoing medical treatment, body mass index, arterial blood pressure, and cardiovascular risk. The cardiovascular risk was based on the Framingham risk score and ultrasonography variables, such as the carotid intima-media thickness and the presence of atherosclerotic plaque in the carotid. Multivariate logistic regression or multiple linear regression analysis was performed at a significance level of 5%.
Results: No differences were observed between groups with regard to age, sex, smoking status, comorbidities, blood pressure, body mass index, lipid profile, and Framingham risk score. In the IBD group, fasting glucose [95 (86.2– 107.3) mg/dL vs 86 (79– 100) mg/dL, p=0.041], carotid intima-media thickness (0.69± 0.12 mm vs 0.63± 0.12 mm, p=0.031), and atherosclerotic carotid plaque (25% vs 5.4%, p=0.032) were higher compared with those in the control group. Multivariate logistic regression analysis showed that patients with IBD presented a 6.45-fold higher risk of carotid atherosclerotic plaque (odds ratio: 6.45; 95% confidence interval: 1.035– 40.216; p< 0.046).
Conclusion: Patients with IBD are at an increased risk of atherosclerosis and, consequently, an increased risk for cardiovascular diseases.
Keywords: cardiovascular risk, carotid artery diseases, carotid intima-media thickness, inflammatory bowel disease
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]